Interv Akut Kardiol. 2022;21(3):150-155 | DOI: 10.36290/kar.2022.022

Has the time come to consider expanding functional assessment of coronary circulation?

Vladimír Rozsíval
Kardiologie, Nemocnice Na Bulovce, Praha

Coronary flow is affected by epicardial arterial stenosis, thrombosis, microcirculation, and dynamic changes - dilatation and spasms (1). For several years, emphasis has been placed on flow reserves which are already firmly embedded in our recommendations (2, 3). The opposite of vasodilatation - vasoconstriction - is neglected in the assessment of circulation. Examination of potential spasms is performed only rarely and non-invasively in our catheterization laboratories. Our Guidelines deal with spasms only minimally and marginally (3). The case report mentions provocation of spasm by hyperventilation which resulted in the temporary closure of a large epicardial artery. The discussion section describes the possibilities and potential significance of spasm induction. Finally, we ask whether the provocation of spasms is of clinical significance and whether we will consider incorporating these methods into the Guidelines.

Keywords: coronary spasm, induction of spasms, case report.

Received: June 28, 2022; Revised: July 21, 2022; Accepted: July 22, 2022; Prepublished online: July 22, 2022; Published: November 21, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rozsíval V. Has the time come to consider expanding functional assessment of coronary circulation? Interv Akut Kardiol. 2022;21(3):150-155. doi: 10.36290/kar.2022.022.
Download citation

References

  1. Gould KL, Lipsocomb K, Hamilton GW. Physiologic basis for assesing critical coronary stenosis: instaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol. 1974;33:87-94. Go to original source... Go to PubMed...
  2. Kovárník T, Jeřábek Š, Kala P. Funkčně vedená revaskularizace myokardu. Interv Akut Kardiol. 2020;19(1):39-46. Go to original source...
  3. Mates M, Kala P, Paleček T, et al. Doporučené postupy ESC pro diagnózu a léčbu chronických koronárních syndromů, 2019. Souhrn dokumentů vypracovaných Českou kardiologickou společností. Cor Vasa. 2020;62:199-233. Go to original source...
  4. Díez-Delhoyo F, Gutiérrez-Ibañes E, Loughlin G, et al. Coronary physiology assessment in the catheterization laboratory. World J Cardiol. 2015;7(9):525-38. Go to original source... Go to PubMed...
  5. Cannon RO, Epstein SE. "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol. 1988;61:1338-43. Go to original source... Go to PubMed...
  6. Zaya M, Mehta PK, Merz CN. Provocative testing for coronary reactivity and spasm. J Am Coll Cardiol. 2014;63:103-109. Go to original source... Go to PubMed...
  7. Spritzler R, Corday E, Bergman HC, et al. Studies on the coronary cirgulation. VIII. Demonstration of spasm of the major coronary arteries. Cardiologia. 1952;21:255-258. Go to original source... Go to PubMed...
  8. Teragawa H, Oshita CH, Ueda T. Coronary spasm: It's common, but it's still unsolved. World J Cardiol. 2018;10(11): 201-209. Go to original source... Go to PubMed...
  9. Yasue H, Nakagawa H, Itoh T, et al. Coronary artery spasm­‑clinical features, diagnosis, pathogenesis and tretment. J Cardiol. 2008;51:2-17. Go to original source... Go to PubMed...
  10. Slavich M, Patel RS. Controversies between diagnosis, pathology, management, prognosis of coronary arery spasms. Int J Cardiol Heart Vasc. 2016;10:47-53. Go to original source... Go to PubMed...
  11. Rahman H, Corcoran D, Aetesam­‑ur­‑Rahman M, et al. Heart. 2019;105:1536-1542. Go to original source... Go to PubMed...
  12. Bairey Merz CN, Pepine CJ, Walsh MN, et al. Ischemia and no obstructive coronary artery disease (INOCA): developing evidence­‑based therapies and research agenda for the next decade. Circulation. 2017;135:1075-1092. Go to original source... Go to PubMed...
  13. Moťovská Z, Kala P, Hutyra M, et al. Doporučení ESC pro léčbu akutních koronárních syndromů u pacientů, prezentujících se bez přetrvávající elevací úseku ST. Cor Vasa. 2021;63(2): 197-234. Go to original source...
  14. Sueda S, Kohno H, Ochi T, et al. Overview of the pharmacological spasm provocation test: Comparisons between acetylcholine and ergonovine. Journal of Cardiology. 2017;69:57-65. Go to original source... Go to PubMed...
  15. Hirano Y, Ozasa Y, Yamamoto T, et al. Hyperventilation and cold pressor stress echocardiography for noninvasive diagnosis of coronary artery spasm. Journal of Cardiology. 2001;14:626-633. Go to original source... Go to PubMed...
  16. Beltrame JF, Crea F, Kski JC, et al. Internatioonal standartization of diagnostic criteria for vasospastic angina. Eur Heart J. 2017;38:2565-2568.
  17. Nakao K, Ohgushi M,Yoshimura M, et al. Hyperventilation as a specific test for diahgnosis of coronary artery spasm. Am J Cardiol. 1997;80(5):545-549. Go to original source... Go to PubMed...
  18. Raizner AE, Chahine RA, Ishimori T, et al. Provocation of coronary artery spasm by the cold pressor test. Circulation. 1980;62:925-930. Go to original source... Go to PubMed...
  19. Waters DD, Szlachcic J, Bonan R, et al. Comparative sensitivity of exercise, cold pressor, and ergonovine testing in provoking attacs af variant angina in patients with active disease. Circulation. 1983;67:310-315. Go to original source... Go to PubMed...
  20. Kaski JC. Testing for coronary artery spasm noninvasively: potentially ideal, but safe? J Am Coll Cardiol img. 2020;13(9): 1888-1890. Go to original source... Go to PubMed...
  21. Serrador A, Roman JM, Duran F, et al. Successful treatment of vasospastic angina with a coronary stent. J Invasive Cardiol. 2000;12:586-588. Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.